Enhancing survival of photoreceptor cells in vivo using the synthetic progestin Norgestrel
- PMID:21689103
- DOI: 10.1111/j.1471-4159.2011.07354.x
Enhancing survival of photoreceptor cells in vivo using the synthetic progestin Norgestrel
Abstract
Retinal degenerations such as Retinitis Pigmentosa remain difficult to treat given the diverse array of genes responsible for their aetiology. Rather than concentrate on specific genes, our focus is on identifying therapeutic avenues for the treatment of retinal disease that target general survival mechanisms or pathways. Norgestrel is a synthetic progestin commonly used in hormonal contraception. Here, we report a novel anti-apoptotic role for Norgestrel in diseased mouse retinas in vivo. Dosing with Norgestrel protects photoreceptor cells from undergoing apoptosis in two distinct models of retinal degeneration; the light damage model and the Pde6b(rd10) model. Photoreceptor rescue was assessed by analysis of cell number, structural integrity and function. Improvements in cell survival of up to 70% were achieved in both disease models, indicating that apoptosis had been halted or at least delayed. A speculative mechanism of action for Norgestrel involves activation of survival pathways in the retina. Indeed, Norgestrel increases the expression of basic fibroblast growth factor which is known to both promote cell survival and inhibit apoptosis. In summary, our results demonstrate significant protection of photoreceptor cells which may be attributed to Norgestrel mediated activation of endogenous survival pathways within the retina.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.
Similar articles
- The synthetic progesterone Norgestrel is neuroprotective in stressed photoreceptor-like cells and retinal explants, mediating its effects via basic fibroblast growth factor, protein kinase A and glycogen synthase kinase 3β signalling.Wyse Jackson AC, Cotter TG.Wyse Jackson AC, et al.Eur J Neurosci. 2016 Apr;43(7):899-911. doi: 10.1111/ejn.13166. Epub 2016 Feb 11.Eur J Neurosci. 2016.PMID:26750157
- Activation of survival pathways in the degenerating retina of rd10 mice.Samardzija M, Wariwoda H, Imsand C, Huber P, Heynen SR, Gubler A, Grimm C.Samardzija M, et al.Exp Eye Res. 2012 Jun;99:17-26. doi: 10.1016/j.exer.2012.04.004. Epub 2012 Apr 21.Exp Eye Res. 2012.PMID:22546314
- Basic fibroblast growth factor-induced protection from light damage in the mouse retina in vivo.O'Driscoll C, O'Connor J, O'Brien CJ, Cotter TG.O'Driscoll C, et al.J Neurochem. 2008 Apr;105(2):524-36. doi: 10.1111/j.1471-4159.2007.05189.x. Epub 2007 Dec 13.J Neurochem. 2008.PMID:18088352
- Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration.Wenzel A, Grimm C, Samardzija M, Remé CE.Wenzel A, et al.Prog Retin Eye Res. 2005 Mar;24(2):275-306. doi: 10.1016/j.preteyeres.2004.08.002. Epub 2004 Nov 11.Prog Retin Eye Res. 2005.PMID:15610977Review.
- On the role of CNTF as a potential therapy for retinal degeneration: Dr. Jekyll or Mr. Hyde?Beltran WA.Beltran WA.Adv Exp Med Biol. 2008;613:45-51. doi: 10.1007/978-0-387-74904-4_4.Adv Exp Med Biol. 2008.PMID:18188927Review.No abstract available.
Cited by
- Micelles of Progesterone for Topical Eye Administration: Interspecies and Intertissues Differences in Ex Vivo Ocular Permeability.Alambiaga-Caravaca AM, Calatayud-Pascual MA, Rodilla V, Concheiro A, López-Castellano A, Alvarez-Lorenzo C.Alambiaga-Caravaca AM, et al.Pharmaceutics. 2020 Jul 26;12(8):702. doi: 10.3390/pharmaceutics12080702.Pharmaceutics. 2020.PMID:32722548Free PMC article.
- Neuroprotection: Pro-survival and Anti-neurotoxic Mechanisms as Therapeutic Strategies in Neurodegeneration.Saragovi HU, Galan A, Levin LA.Saragovi HU, et al.Front Cell Neurosci. 2019 Jun 6;13:231. doi: 10.3389/fncel.2019.00231. eCollection 2019.Front Cell Neurosci. 2019.PMID:31244606Free PMC article.Review.
- Progesterone, Lipoic Acid, and Sulforaphane as Promising Antioxidants for Retinal Diseases: A Review.Hernández-Rabaza V, López-Pedrajas R, Almansa I.Hernández-Rabaza V, et al.Antioxidants (Basel). 2019 Mar 2;8(3):53. doi: 10.3390/antiox8030053.Antioxidants (Basel). 2019.PMID:30832304Free PMC article.Review.
- Potential neuroprotective biomolecules in ophthalmology.Afarid M, Sanie-Jahromi F.Afarid M, et al.Int Ophthalmol. 2021 Mar;41(3):1103-1109. doi: 10.1007/s10792-020-01634-8. Epub 2020 Nov 12.Int Ophthalmol. 2021.PMID:33180279Review.
- Role of Gonadal Steroid Hormones in the Eye: Therapeutic Implications.Valero-Ochando J, Cantó A, López-Pedrajas R, Almansa I, Miranda M.Valero-Ochando J, et al.Biomolecules. 2024 Oct 7;14(10):1262. doi: 10.3390/biom14101262.Biomolecules. 2024.PMID:39456195Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources